- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Yantai Dongcheng Pharmaceutical Co Ltd (002675)
Yantai Dongcheng Pharmaceutical Co Ltd stock price live, this page displays SZ 002675 stock exchange data. View the 002675 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Yantai Dongcheng Pharmaceutical Co Ltd real time stock price chart below.
What Is the Yantai Dongcheng Pharmaceutical Co Ltd Stock Price Today?
The Yantai Dongcheng Pharmaceutical Co Ltd stock price today is 17.19.
What Is the Stock Symbol for Yantai Dongcheng Pharmaceutical Co Ltd?
The stock symbol for Yantai Dongcheng Pharmaceutical Co Ltd is ""002675.""
What Stock Exchange Does Yantai Dongcheng Pharmaceutical Co Ltd Trade On?
Yantai Dongcheng Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Yantai Dongcheng Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Yantai Dongcheng Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002675 quote. (ISIN: CNE100001DP5)
What Is the Yantai Dongcheng Pharmaceutical Co Ltd Stock Price Today?
The Yantai Dongcheng Pharmaceutical Co Ltd stock price today is 17.19.
What Is the Stock Symbol for Yantai Dongcheng Pharmaceutical Co Ltd?
The stock symbol for Yantai Dongcheng Pharmaceutical Co Ltd is ""002675.""
What Stock Exchange Does Yantai Dongcheng Pharmaceutical Co Ltd Trade On?
Yantai Dongcheng Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Yantai Dongcheng Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Yantai Dongcheng Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002675 quote. (ISIN: CNE100001DP5)
Shenzhen
Currency in CNY
17.19
-0.18(-1.04%)
Closed·
Fair Value
An estimate of a Yantai Dongcheng Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.90
17.36
52 wk Range
11.37
18.35
002675 Scorecard
Full Analysis
Net income is expected to grow this year
002675 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Yantai Dongcheng Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.9017.36
52 wk Range
11.3718.35
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.19%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
002675 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Yantai Dongcheng Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
15.50
Downside
-9.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Yantai Dongcheng Pharmaceutical Co Ltd Company Profile
Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C. The company also provides nadroparin calcium, hydrocortisone sodium succinate, chorionic gonadotrophin, and menotropins for injection, as well as ambroxol hydrochloride dispersible tablets, jinjunling capsule, metformin hydrochloride and glibenclamide tablets, clemastine fumarate tablets, and wind dispelling itch relieving granule. In addition, it offers Technetium [99Tc] Methylene Diphosphonate Injection; Technetium [99mTc] Tc labeled tracers; 2-[18F]FDG that helps to detect the activity of tumor cells; sodium iodide [131I] oral solution; iodine [125I] seed use to treat internal radiation of various malignant tumors; [14C]Urea capsule; and jiabaolin glucosamine chondroitin sulfate capsule. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.
Compare 002675 to Peers and Sector
Metrics to compare | 002675 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002675PeersSector | |
|---|---|---|---|---|
P/E Ratio | 98.3x | 38.9x | −0.5x | |
PEG Ratio | −2.76 | −0.26 | 0.00 | |
Price/Book | 3.2x | 2.3x | 2.6x | |
Price / LTM Sales | 4.9x | 7.5x | 3.3x | |
Upside (Analyst Target) | −6.9% | 5.5% | 43.5% | |
Fair Value Upside | Unlock | 9.7% | 6.8% | Unlock |
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 15.50
(-9.83% Downside)
Earnings
Latest Release
Apr 29, 2025
EPS / Forecast
0.03 / --
Revenue / Forecast
686.93M / --
FAQ
What Stock Exchange Does Yantai Dongcheng Pharma Trade On?
Yantai Dongcheng Pharma is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Yantai Dongcheng Pharma?
The stock symbol for Yantai Dongcheng Pharma is "002675."
What Is the Yantai Dongcheng Pharma Market Cap?
As of today, Yantai Dongcheng Pharma market cap is 14.17B.
What Is Yantai Dongcheng Pharma's Earnings Per Share (TTM)?
The Yantai Dongcheng Pharma EPS (TTM) is 0.17.
When Is the Next Yantai Dongcheng Pharma Earnings Date?
Yantai Dongcheng Pharma will release its next earnings report on 23 Oct 2025.
From a Technical Analysis Perspective, Is 002675 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Yantai Dongcheng Pharma Stock Split?
Yantai Dongcheng Pharma has split 2 times.
How Many Employees Does Yantai Dongcheng Pharma Have?
Yantai Dongcheng Pharma has 2469 employees.
What is the current trading status of Yantai Dongcheng Pharma (002675)?
As of 09 Aug 2025, Yantai Dongcheng Pharma (002675) is trading at a price of 17.19, with a previous close of 17.37. The stock has fluctuated within a day range of 16.90 to 17.36, while its 52-week range spans from 11.37 to 18.35.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.